Ferric pyrophosphate citrate
- Generic Name
- Ferric pyrophosphate citrate
- Brand Names
- Triferic
- Drug Type
- Small Molecule
- Chemical Formula
- C18H24Fe4O42P6
- CAS Number
- 1802359-96-1
- Unique Ingredient Identifier
- UBY79OCO9G
- Background
Ferric pyrophosphate citrate is a soluble iron replacement product. Free iron presents several side effects as it can catalyze free radical formation and lipid peroxidation as well as the presence of interactions of iron in plasma. The ferric ion is strongly complexed by pyrophosphate and citrate. FPC is categorized in Japan as a second class OTC drug. This ...
- Indication
Ferric pyrophosphate citrate is indicated for the treatment of iron loss or iron deficiency to maintain hemoglobin and to reduce the prescribed dose of erythropoiesis-stimulating agent (ESA) required to maintain desired hemoglobin levels.
...
- Associated Conditions
- Iron Deficiency (ID)
- Associated Therapies
- -
Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis
- Conditions
- Interventions
- First Posted Date
- 2012-01-02
- Last Posted Date
- 2016-10-25
- Lead Sponsor
- Rockwell Medical Technologies, Inc.
- Target Recruit Count
- 718
- Registration Number
- NCT01503021
- Locations
- 🇺🇸
Research Across America, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.